Compare McKesson Corporation (MCK) vs Nu Holdings Ltd (NU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Nu Holdings Ltd — how do they compare? McKesson Corporation trades at $829.95 (market cap $97.35B), while Nu Holdings Ltd trades at $14.02 (market cap $67.58B). The key difference: McKesson Corporation is the larger of the two by market cap, and McKesson Corporation pays a 0.39% dividend while Nu Holdings Ltd pays none. Which is the better fit depends on your goals.
| MCK | NU | |
|---|---|---|
Market Cap | $97.35B | $67.58B |
Sector | Health | Financials |
52-Week High | $995.69 | $18.76 |
52-Week Low | $659.01 | $11.60 |
Enterprise Value | $101.98B | — |
Dividend Yield | 0.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
NU stock trades at $14.125, up 3.94% today, with a bearish technical signal but strong fundamentals including 26.72% net income margin and 30.04% ROE. Recent earnings show mixed results with two misses, but revenue growth accelerated from $3.0B in 2022 to $10.63B in 2025. The company secured banking approval in Mexico, expanding its Latin American footprint to 15 million customers as of July 2026 (Bloomberg, 2026-07-15).
Outlook remains positive with a $14.98 consensus price target (54.55% buy ratings), though risks include high P/E of 20.96 and debt-to-asset ratio volatility. Growth catalysts from Mexico expansion and digital banking dominance support long-term potential, but near-term headwinds from earnings misses and competitive pressures warrant caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Nu Holdings Ltd
Nu Holdings Ltd is engaged in providing digital banking services. It offers several financial services such as Credit cards, Personal Account, Investments, Personal Loans, Insurance, Mobile payments, Business Account, and Rewards.
Read more on NU →
